• Serine and Arginine-rich Splicing Factor 2 (SRSF2) Gene Mutation Analysis
  • Idiopathic Pulmonary Fibrosis Diagnostic Test (Envisia™)
  • Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • Hereditary Hemorrhagic Telangiectasia, ACVRL1 Gene Mutation Analysis
  • Chlamydia trachomatis NA, Urine
  • Flunitrazepam, Urine
  • Immunoglobulins, CSF Quantitative
  • Gastrointestinal Parasite Pathogen Panel, Molecular
  • CALU Gene Mutation Analysis
  • T-Cell Receptor Gene Rearrangement, FISH, Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Peritoneal Fluid
Medical Test

Turnaround Time
Access to Cancer Antigen (CA) 19-9, Peritoneal Fluid is restricted.